These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 28780425)
1. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy. Gowen BB; Westover JB; Sefing EJ; Van Wettere AJ; Bailey KW; Wandersee L; Komeno T; Furuta Y Antiviral Res; 2017 Sep; 145():131-135. PubMed ID: 28780425 [TBL] [Abstract][Full Text] [Related]
2. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever. Gowen BB; Juelich TL; Sefing EJ; Brasel T; Smith JK; Zhang L; Tigabu B; Hill TE; Yun T; Pietzsch C; Furuta Y; Freiberg AN PLoS Negl Trop Dis; 2013; 7(12):e2614. PubMed ID: 24386500 [TBL] [Abstract][Full Text] [Related]
3. Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease. Westover JB; Bailey KW; Wasson SR; Boardman KM; Lustig KH; Amberg SM; Gowen BB Antiviral Res; 2024 Sep; 229():105952. PubMed ID: 38945484 [TBL] [Abstract][Full Text] [Related]
4. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever. Mendenhall M; Russell A; Smee DF; Hall JO; Skirpstunas R; Furuta Y; Gowen BB PLoS Negl Trop Dis; 2011 Oct; 5(10):e1342. PubMed ID: 22022624 [TBL] [Abstract][Full Text] [Related]
5. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. Westover JB; Sefing EJ; Bailey KW; Van Wettere AJ; Jung KH; Dagley A; Wandersee L; Downs B; Smee DF; Furuta Y; Bray M; Gowen BB Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718 [TBL] [Abstract][Full Text] [Related]
6. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses. Hickerson BT; Westover JB; Wang Z; Lee YM; Gowen BB J Virol; 2020 Jan; 94(4):. PubMed ID: 31748396 [TBL] [Abstract][Full Text] [Related]
7. Potential and action mechanism of favipiravir as an antiviral against Junin virus. Zadeh VR; Afowowe TO; Abe H; Urata S; Yasuda J PLoS Pathog; 2022 Jul; 18(7):e1010689. PubMed ID: 35816544 [TBL] [Abstract][Full Text] [Related]
8. Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir. Westover JB; Naik S; Bailey KW; Wandersee L; Gantla VR; Hickerson BT; McCormack K; Henkel G; Gowen BB Antiviral Res; 2022 Dec; 208():105444. PubMed ID: 36243175 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever. Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247 [TBL] [Abstract][Full Text] [Related]
14. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever. Seregin AV; Yun NE; Miller M; Aronson J; Smith JK; Walker AG; Smith JN; Huang C; Manning JT; de la Torre JC; Paessler S J Virol; 2015 Jun; 89(11):5949-56. PubMed ID: 25810546 [TBL] [Abstract][Full Text] [Related]
15. Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020. Veliziotis I; Roman A; Martiny D; Schuldt G; Claus M; Dauby N; Van den Wijngaert S; Martin C; Nasreddine R; Perandones C; Mahieu R; Swaan C; Van Praet S; Konopnicki D; Morales MA; Malvy D; Stevens E; Dechamps P; Vlieghe E; Vandenberg O; Günther S; Gérard M Emerg Infect Dis; 2020 Jul; 26(7):1562-1566. PubMed ID: 32271701 [TBL] [Abstract][Full Text] [Related]
16. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates. Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218 [TBL] [Abstract][Full Text] [Related]
17. Activity of a phenolic dibenzylsulfide against New World arenavirus infections. Gowen BB; Jung KH; Sefing EJ; Wong MH; Westover JB; Smee DF Antivir Chem Chemother; 2014 Jan; 23(4):151-9. PubMed ID: 23337126 [TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor. Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630 [TBL] [Abstract][Full Text] [Related]
19. Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs. Kenyon RH; Canonico PG; Green DE; Peters CJ Antimicrob Agents Chemother; 1986 Mar; 29(3):521-3. PubMed ID: 3013087 [TBL] [Abstract][Full Text] [Related]